Srilakshmi (Sri) Sharma has been a Consultant Medical Ophthalmologist in Oxford University Hospitals NHS Trust since 2013 . She has also been a Consultant in Medical Retina in Moorfields Eye Hospital.
Dr Sharma’s practice
Ocular Inflammation– Uveitis and scleritis in adults and children
Retinal conditions e.g Age related macular degeneration, vein occlusions , diabetic retinopathy
Neuroophthalmology conditions e.g swollen optic nerves, optic neuritis , brain tumours which impinge on the visual pathway, myasthenia gravis, blepharospasm
Other Inflammatory conditions e.g uveitis in adults and children, scleritis, dry eye
Systemic diseases ie diseases which affect more than one part of the body and which afffect the eye eg rheumatoid arthritis , sarcoidosis or multiple sclerosis
Dr Sharma also has functional medicine approach to retinal, inflammatory conditions and neuroophthalmic conditions which can benefit some patients.
A little background
After qualifying at Bristol University, Dr Sharma first trained in General Medicine and later in Medical Ophthalmology at Bristol Eye Hospital. She completed fellowships in Uveitis and Neuroophthalmology at The Casey Eye Institute and The John Hopkins’ Hospital in the United States of America . She worked in Moorfield Eye Hospital as a Retinal Consultant before working in Oxford full- time as a Medical Ophthalmologist.
Dr Sharma leads the Adult and Children’s Ocular Inflammation (Uveitis) service based at Oxford for the Thames Valley region. She is also the lead for Neurophthalmology at The Oxford Eye Hospital. Overall, her clinical role serves a catchment area of 1 million people. She is also the Ophthalmic lead for the national neurofibromatosis 2 service and neuromyelitis optica services based at Oxford.
Research and Other Activities
Dr Sharma is the founder and Chair for the Uveitis National Clinical Study Group. Her research involves understanding the role of targeted therapies in uveitis. She is co- chief investigator the national NIHR-funded ASTUTE trial and an MRC Fellow , based at the Kennedy Institute at Oxford University studying the underlying causes of uveitis within ocular tissues. She is also a co-Investigator for a genomics study in optic neuritis. She is a Principal Investigator for the British Ophthalmic Surveillance Unit study of hydroxychloroquine toxicity in the eye in the UK. and a founding member of ORBIT, a collaboration of clinicians and scientists committed to increasing the understanding of how the eye becomes involved in systemic inflammatory diseases.
Other profile Links: